Skip to content

Adaptive Immunity Source Review Notes

Scope

This audit records a private-wiki source-review pass completed on 2026-04-30.

The pass screened the local ILC source library for evidence that ILCs regulate adaptive immunity, with emphasis on T cells, B cells, and Tregs. Six previously provisional sources were promoted to source-reviewed evidence notes. Already focused OX40L and CTLA-4 sources were reused as supporting anchors rather than duplicated.

Sources Promoted

Selection Logic

  • Included: sources with direct ILC-to-T-cell, ILC-to-Treg, or ILC-to-B-cell mechanisms.
  • Included: review-level ILC-T-cell synthesis for orientation only.
  • Not upgraded here: sources where T cells or B cells were background disease context without a direct ILC-adaptive-immunity mechanism.

Knowledge-Layer Changes

  • Added ILC Regulation Of Adaptive Immunity as a topic page.
  • Updated the ILC2 and ILC3 entity hubs to point readers toward adaptive-immunity crosstalk.
  • Updated ILC2 and ILC3 mechanism pages with OX40L, MHCII, IL-2, alphaV integrin, CD40L, BAFF, IL-15, and CTLA-4-linked adaptive-immunity branches.
  • Updated the core evidence synthesis with a tissue-boundary-aware adaptive-immunity layer.

Interpretation Limits

  • Lung-direct evidence is currently strongest for mouse ILC2 OX40L regulation of local Th2/Treg expansion.
  • ILC3 adaptive-immunity evidence is strong mechanistically but mostly gut, tonsil, or blood context in the current library.
  • Review-level ILC-T-cell framing should not substitute for primary source citations.